CVS Health recorded a net income of $1.8 billion in the first quarter of 2025, up from $1.1 billion during the same period last year, according to its May 1 financial report.
CVS Health
The company reported total revenue of $94.6 billion during the three months ended March 31, up from $88.4 billion posted during the same period last year.
Total operating costs were $91.2 billion in the quarter, up from $86.2 billion last year.
Operating income was $3.4 billion, up from $2.3 billion.
Healthcare benefits segment (Aetna)
Aetna reported total revenue of $34.8 billion in the first quarter, an 8% increase year over year.
Adjusted operating income was $2 billion, a 172.3% increase year over year.
Aetna had a medical benefit ratio of 87.3%, compared to 90.4% during the same quarter last year.
Medical membership as of March 31 was 27.1 million, up from 26.8 million on the same date last year.
At the end of the quarter, Aetna had 18.8 million commercial members, 4.2 million Medicare Advantage members, 1.3 million supplement members, 2.4 million Medicaid members and 4.1 million Medicare Part D plan members.
CVS Health said that Aetna will exit the individual exchange business in 2026.
Health services segment
The segment recorded total revenue of $43.5 billion in the quarter, a 7.9% increase year over year.
Adjusted operating income was $1.6 billion, a 17.6% increase year over year.
Total pharmacy claims processed was 464.2 million, a 0.3% increase year over year.
CVS Caremark is partnering with Novo Nordisk to “significantly increase access” to weight loss drug Wegovy. CVS will take formulary action July 1 to prefer Wegovy for its members.
“The company will enhance the value of these new medications by combining them with additional lifestyle clinical support as part of the CVS weight management program offered to clients through CVS Caremark,” according to the report.
Pharmacy and consumer wellness segment
The segment posted total revenue of $31.9 billion, up 11.1% year over year.
Adjusted operating income was $1.3 billion, an 11.6% increase year over year.
Prescriptions filled on a 30-day equivalent basis increased 4.3% year over year to 435.5 million.
